Thermo Fisher Scientific Inc. (0R0H.L)
USD 444.49
(-5.68%)
USD 444.49
(-5.68%)
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2023 | 98.72 Billion USD | 1.62% |
| 2022 | 97.15 Billion USD | 2.14% |
| 2021 | 95.12 Billion USD | 37.76% |
| 2020 | 69.05 Billion USD | 18.28% |
| 2019 | 58.38 Billion USD | 3.82% |
| 2018 | 56.23 Billion USD | -0.77% |
| 2017 | 56.66 Billion USD | 23.44% |
| 2016 | 45.9 Billion USD | 12.43% |
| 2015 | 40.83 Billion USD | -4.71% |
| 2014 | 42.85 Billion USD | 34.49% |
| 2013 | 31.86 Billion USD | 16.1% |
| 2012 | 27.44 Billion USD | 2.28% |
| 2011 | 26.83 Billion USD | 25.47% |
| 2010 | 21.38 Billion USD | -0.99% |
| 2009 | 21.6 Billion USD | 2.42% |
| 2008 | 21.09 Billion USD | -0.55% |
| 2007 | 21.2 Billion USD | -0.26% |
| 2006 | 21.26 Billion USD | 400.1% |
| 2005 | 4.25 Billion USD | 18.87% |
| 2004 | 3.57 Billion USD | 5.54% |
| 2003 | 3.38 Billion USD | -7.08% |
| 2002 | 3.64 Billion USD | -4.65% |
| 2001 | 3.82 Billion USD | -21.34% |
| 2000 | 4.86 Billion USD | -6.15% |
| 1999 | 5.18 Billion USD | -18.16% |
| 1998 | 6.33 Billion USD | 9.24% |
| 1997 | 5.79 Billion USD | 12.73% |
| 1996 | 5.14 Billion USD | 37.29% |
| 1995 | 3.74 Billion USD | 24.01% |
| 1994 | 3.01 Billion USD | 22.08% |
| 1993 | 2.47 Billion USD | 36.04% |
| 1992 | 1.81 Billion USD | 51.59% |
| 1991 | 1.19 Billion USD | 33.54% |
| 1990 | 898.2 Million USD | 44.03% |
| 1989 | 623.6 Million USD | 27.24% |
| Year | Total Assets | Total Assets Growth |
|---|---|---|
| 2024 Q3 | 100.36 Billion USD | 1.9% |
| 2024 Q1 | 97.09 Billion USD | -1.65% |
| 2024 Q2 | 98.49 Billion USD | 1.44% |
| 2023 Q1 | 94.65 Billion USD | -2.57% |
| 2023 Q3 | 97.05 Billion USD | 3.14% |
| 2023 FY | 98.72 Billion USD | 1.62% |
| 2023 Q2 | 94.1 Billion USD | -0.58% |
| 2023 Q4 | 98.72 Billion USD | 1.72% |
| 2022 Q1 | 92.74 Billion USD | -2.5% |
| 2022 FY | 97.15 Billion USD | 2.14% |
| 2022 Q4 | 97.15 Billion USD | 7.31% |
| 2022 Q3 | 90.53 Billion USD | -0.05% |
| 2022 Q2 | 90.57 Billion USD | -2.34% |
| 2021 Q3 | 73.6 Billion USD | 8.72% |
| 2021 Q4 | 95.12 Billion USD | 29.24% |
| 2021 Q1 | 65.93 Billion USD | -4.52% |
| 2021 FY | 95.12 Billion USD | 37.76% |
| 2021 Q2 | 67.69 Billion USD | 2.68% |
| 2020 Q2 | 61.59 Billion USD | 4.95% |
| 2020 Q3 | 64.06 Billion USD | 4.01% |
| 2020 Q4 | 69.05 Billion USD | 7.79% |
| 2020 FY | 69.05 Billion USD | 18.28% |
| 2020 Q1 | 58.68 Billion USD | 0.53% |
| 2019 Q4 | 58.38 Billion USD | 2.91% |
| 2019 FY | 58.38 Billion USD | 3.82% |
| 2019 Q1 | 55.59 Billion USD | -1.13% |
| 2019 Q3 | 56.72 Billion USD | -2.14% |
| 2019 Q2 | 57.97 Billion USD | 4.27% |
| 2018 Q3 | 55.07 Billion USD | -0.59% |
| 2018 Q4 | 56.23 Billion USD | 2.1% |
| 2018 FY | 56.23 Billion USD | -0.77% |
| 2018 Q1 | 56.58 Billion USD | -0.16% |
| 2018 Q2 | 55.4 Billion USD | -2.08% |
| 2017 Q1 | 46.21 Billion USD | 0.67% |
| 2017 FY | 56.66 Billion USD | 23.44% |
| 2017 Q3 | 55.98 Billion USD | 20.36% |
| 2017 Q4 | 56.66 Billion USD | 1.22% |
| 2017 Q2 | 46.51 Billion USD | 0.65% |
| 2016 Q1 | 42.95 Billion USD | 5.19% |
| 2016 Q2 | 42.25 Billion USD | -1.63% |
| 2016 Q3 | 48.01 Billion USD | 13.63% |
| 2016 Q4 | 45.9 Billion USD | -4.38% |
| 2016 FY | 45.9 Billion USD | 12.43% |
| 2015 Q3 | 41.14 Billion USD | -1.5% |
| 2015 FY | 40.83 Billion USD | -4.71% |
| 2015 Q1 | 41.85 Billion USD | -2.32% |
| 2015 Q2 | 41.77 Billion USD | -0.2% |
| 2015 Q4 | 40.83 Billion USD | -0.76% |
| 2014 Q4 | 42.85 Billion USD | 0.38% |
| 2014 Q3 | 42.69 Billion USD | -3.66% |
| 2014 Q2 | 44.31 Billion USD | -3.95% |
| 2014 Q1 | 46.13 Billion USD | 44.79% |
| 2014 FY | 42.85 Billion USD | 34.49% |
| 2013 Q1 | 27.41 Billion USD | -0.12% |
| 2013 Q4 | 31.86 Billion USD | 12.7% |
| 2013 Q3 | 28.27 Billion USD | 2.33% |
| 2013 Q2 | 27.62 Billion USD | 0.8% |
| 2013 FY | 31.86 Billion USD | 16.1% |
| 2012 FY | 27.44 Billion USD | 2.28% |
| 2012 Q4 | 27.44 Billion USD | -0.48% |
| 2012 Q3 | 27.57 Billion USD | 4.62% |
| 2012 Q1 | 26.82 Billion USD | -0.04% |
| 2012 Q2 | 26.36 Billion USD | -1.72% |
| 2011 FY | 26.83 Billion USD | 25.47% |
| 2011 Q4 | 26.83 Billion USD | -0.58% |
| 2011 Q3 | 26.99 Billion USD | 12.12% |
| 2011 Q2 | 24.07 Billion USD | 2.75% |
| 2011 Q1 | 23.43 Billion USD | 9.75% |
| 2010 Q1 | 21.62 Billion USD | -0.0% |
| 2010 FY | 21.38 Billion USD | -0.99% |
| 2010 Q3 | 21.53 Billion USD | 1.2% |
| 2010 Q4 | 21.34 Billion USD | -0.87% |
| 2010 Q2 | 21.28 Billion USD | -1.59% |
| 2009 FY | 21.6 Billion USD | 2.42% |
| 2009 Q2 | 21.15 Billion USD | 0.58% |
| 2009 Q1 | 21.03 Billion USD | -0.27% |
| 2009 Q4 | 21.62 Billion USD | 0.96% |
| 2009 Q3 | 21.41 Billion USD | 1.24% |
| 2008 Q2 | 21.68 Billion USD | 0.85% |
| 2008 Q1 | 21.49 Billion USD | 1.37% |
| 2008 FY | 21.09 Billion USD | -0.55% |
| 2008 Q3 | 21.59 Billion USD | -0.38% |
| 2008 Q4 | 21.09 Billion USD | -2.36% |
| 2007 Q2 | 21.27 Billion USD | 0.47% |
| 2007 Q1 | 21.17 Billion USD | -0.42% |
| 2007 FY | 21.2 Billion USD | -0.26% |
| 2007 Q3 | 21.17 Billion USD | -0.47% |
| 2007 Q4 | 21.2 Billion USD | 0.17% |
| 2006 FY | 21.26 Billion USD | 400.1% |
| 2006 Q3 | 4.19 Billion USD | 0.53% |
| 2006 Q1 | 4.24 Billion USD | -0.26% |
| 2006 Q2 | 4.17 Billion USD | -1.52% |
| 2006 Q4 | 21.26 Billion USD | 406.46% |
| 2005 Q4 | 4.25 Billion USD | 2.55% |
| 2005 Q1 | 3.55 Billion USD | -0.62% |
| 2005 FY | 4.25 Billion USD | 18.87% |
| 2005 Q2 | 4.13 Billion USD | 16.32% |
| 2005 Q3 | 4.14 Billion USD | 0.28% |
| 2004 Q2 | 3.49 Billion USD | 1.23% |
| 2004 Q1 | 3.45 Billion USD | 1.9% |
| 2004 Q3 | 3.36 Billion USD | -3.67% |
| 2004 FY | 3.57 Billion USD | 5.54% |
| 2004 Q4 | 3.57 Billion USD | 6.21% |
| 2003 FY | 3.38 Billion USD | -7.08% |
| 2003 Q1 | 3.4 Billion USD | -6.59% |
| 2003 Q2 | 3.27 Billion USD | -3.72% |
| 2003 Q3 | 3.12 Billion USD | -4.79% |
| 2003 Q4 | 3.38 Billion USD | 8.52% |
| 2002 Q1 | 3.88 Billion USD | 1.48% |
| 2002 Q2 | 3.79 Billion USD | -2.19% |
| 2002 Q4 | 3.64 Billion USD | -0.73% |
| 2002 Q3 | 3.67 Billion USD | -3.23% |
| 2002 FY | 3.64 Billion USD | -4.65% |
| 2001 FY | 3.82 Billion USD | -21.34% |
| 2001 Q4 | 3.82 Billion USD | -12.59% |
| 2001 Q3 | 4.37 Billion USD | -6.84% |
| 2001 Q2 | 4.69 Billion USD | -1.82% |
| 2001 Q1 | 4.78 Billion USD | -1.63% |
| 2000 Q4 | 4.86 Billion USD | -3.56% |
| 2000 Q1 | 5.17 Billion USD | -0.09% |
| 2000 Q2 | 5.14 Billion USD | -0.59% |
| 2000 Q3 | 5.04 Billion USD | -2.03% |
| 2000 FY | 4.86 Billion USD | -6.15% |
| 1999 Q2 | 5.93 Billion USD | -6.54% |
| 1999 Q4 | 5.18 Billion USD | -14.6% |
| 1999 Q3 | 6.06 Billion USD | 2.23% |
| 1999 Q1 | 6.35 Billion USD | 0.3% |
| 1999 FY | 5.18 Billion USD | -18.16% |
| 1998 Q2 | 6.43 Billion USD | 5.32% |
| 1998 Q3 | 6.24 Billion USD | -2.98% |
| 1998 Q1 | 6.11 Billion USD | 5.43% |
| 1998 FY | 6.33 Billion USD | 9.24% |
| 1998 Q4 | 6.33 Billion USD | 1.4% |
| 1997 Q2 | 5.3 Billion USD | -0.73% |
| 1997 Q3 | 5.58 Billion USD | 5.34% |
| 1997 Q4 | 5.79 Billion USD | 3.72% |
| 1997 FY | 5.79 Billion USD | 12.73% |
| 1997 Q1 | 5.34 Billion USD | 3.94% |
| 1996 Q3 | 4.94 Billion USD | 1.0% |
| 1996 Q4 | 5.14 Billion USD | 3.87% |
| 1996 FY | 5.14 Billion USD | 37.29% |
| 1996 Q1 | 4.63 Billion USD | 23.86% |
| 1996 Q2 | 4.9 Billion USD | 5.65% |
| 1995 Q3 | 3.5 Billion USD | 5.77% |
| 1995 Q1 | 3.14 Billion USD | 4.13% |
| 1995 Q2 | 3.31 Billion USD | 5.44% |
| 1995 Q4 | 3.74 Billion USD | 6.78% |
| 1995 FY | 3.74 Billion USD | 24.01% |
| 1994 FY | 3.01 Billion USD | 22.08% |
| 1994 Q3 | 2.97 Billion USD | 1.4% |
| 1994 Q4 | 3.01 Billion USD | 1.51% |
| 1994 Q2 | 2.93 Billion USD | 14.22% |
| 1994 Q1 | 2.56 Billion USD | 3.84% |
| 1993 Q2 | 1.9 Billion USD | 1.62% |
| 1993 Q1 | 1.87 Billion USD | 3.29% |
| 1993 Q4 | 2.47 Billion USD | 8.26% |
| 1993 FY | 2.47 Billion USD | 36.04% |
| 1993 Q3 | 2.28 Billion USD | 19.71% |
| 1992 Q1 | 1.35 Billion USD | 13.11% |
| 1992 Q2 | 1.4 Billion USD | 3.88% |
| 1992 Q4 | 1.81 Billion USD | 2.59% |
| 1992 FY | 1.81 Billion USD | 51.59% |
| 1992 Q3 | 1.77 Billion USD | 25.76% |
| 1991 Q1 | 956.6 Million USD | 6.5% |
| 1991 Q3 | 1.08 Billion USD | 11.15% |
| 1991 Q4 | 1.19 Billion USD | 10.55% |
| 1991 FY | 1.19 Billion USD | 33.54% |
| 1991 Q2 | 976.2 Million USD | 2.05% |
| 1990 Q3 | 864.6 Million USD | 4.4% |
| 1990 FY | 898.2 Million USD | 44.03% |
| 1990 Q1 | 613.7 Million USD | -1.59% |
| 1990 Q2 | 828.2 Million USD | 34.95% |
| 1990 Q4 | 898.2 Million USD | 3.89% |
| 1989 FY | 623.6 Million USD | 27.24% |
| 1989 Q3 | 564.7 Million USD | 0.0% |
| 1989 Q4 | 623.6 Million USD | 10.43% |
| Name | Total Assets | Total Assets Difference |
|---|---|---|
| uniQure N.V. | 831.68 Million USD | -11770.543% |
| Agios Pharmaceuticals, Inc. | 937.11 Million USD | -10435.066% |
| Amicus Therapeutics, Inc. | 777.88 Million USD | -12591.675% |
| Atara Biotherapeutics, Inc. | 165.5 Million USD | -59551.73% |
| bluebird bio, Inc. | 619.16 Million USD | -15845.126% |
| Cara Therapeutics, Inc. | 125.84 Million USD | -78351.098% |
| Imunon, Inc. | 21.91 Million USD | -450332.016% |
| Editas Medicine, Inc. | 499.15 Million USD | -19678.705% |
| IQVIA Holdings Inc. | 26.68 Billion USD | -270.024% |
| Mettler-Toledo International Inc. | 3.35 Billion USD | -2842.166% |
| Myriad Genetics, Inc. | 1.19 Billion USD | -8136.089% |
| Neurocrine Biosciences, Inc. | 3.25 Billion USD | -2936.415% |
| Supernus Pharmaceuticals, Inc. | 1.4 Billion USD | -6906.928% |
| Verastem, Inc. | 149.71 Million USD | -65841.303% |
| Walgreens Boots Alliance, Inc. | 81.03 Billion USD | -21.828% |
| Waters Corporation | 4.62 Billion USD | -2033.761% |
| Biogen Inc. | 26.84 Billion USD | -267.766% |
| Nektar Therapeutics | 398.03 Million USD | -24703.471% |
| Perrigo Company plc | 10.8 Billion USD | -813.36% |
| Dynavax Technologies Corporation | 997.09 Million USD | -9801.354% |
| Illumina, Inc. | 10.11 Billion USD | -876.422% |
| Corbus Pharmaceuticals Holdings, Inc. | 28.27 Million USD | -349095.768% |
| Iovance Biotherapeutics, Inc. | 780.35 Million USD | -12551.486% |
| Heron Therapeutics, Inc. | 222.5 Million USD | -44270.039% |
| Unity Biotechnology, Inc. | 65.69 Million USD | -150190.76% |
| BioMarin Pharmaceutical Inc. | 6.84 Billion USD | -1343.024% |
| Sangamo Therapeutics, Inc. | 165.32 Million USD | -59618.122% |
| Evolus, Inc. | 188.99 Million USD | -52136.532% |
| Adicet Bio, Inc. | 207.29 Million USD | -47525.847% |
| Aclaris Therapeutics, Inc. | 197.4 Million USD | -49911.904% |
| Regeneron Pharmaceuticals, Inc. | 33.08 Billion USD | -198.444% |
| Esperion Therapeutics, Inc. | 205.79 Million USD | -47872.75% |
| FibroGen, Inc. | 423.52 Million USD | -23210.328% |
| Agilent Technologies, Inc. | 10.76 Billion USD | -817.272% |
| OPKO Health, Inc. | 2.01 Billion USD | -4807.595% |
| Homology Medicines, Inc. | 47.05 Million USD | -209700.88% |
| Geron Corporation | 394.07 Million USD | -24952.528% |
| Alnylam Pharmaceuticals, Inc. | 3.82 Billion USD | -2477.783% |
| Exelixis, Inc. | 2.94 Billion USD | -3255.337% |
| Viking Therapeutics, Inc. | 368.49 Million USD | -26692.043% |
| Anavex Life Sciences Corp. | 154.38 Million USD | -63847.508% |
| Intellia Therapeutics, Inc. | 1.3 Billion USD | -7488.605% |
| Zoetis Inc. | 14.28 Billion USD | -591.068% |
| Axsome Therapeutics, Inc. | 588.23 Million USD | -16683.4% |
| Abeona Therapeutics Inc. | 64 Million USD | -154154.557% |
| Vertex Pharmaceuticals Incorporated | 22.73 Billion USD | -334.338% |
| Kala Pharmaceuticals, Inc. | 55.94 Million USD | -176357.131% |
| Ionis Pharmaceuticals, Inc. | 2.99 Billion USD | -3201.793% |
| Sarepta Therapeutics, Inc. | 3.26 Billion USD | -2924.16% |
| Corcept Therapeutics Incorporated | 621.51 Million USD | -15784.682% |
| Halozyme Therapeutics, Inc. | 1.73 Billion USD | -5595.939% |
| Blueprint Medicines Corporation | 1.04 Billion USD | -9309.197% |
| Insmed Incorporated | 1.32 Billion USD | -7323.917% |
| TG Therapeutics, Inc. | 329.58 Million USD | -29854.458% |
| Incyte Corporation | 6.78 Billion USD | -1355.683% |
| Emergent BioSolutions Inc. | 1.83 Billion USD | -5280.457% |